These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21555186)

  • 1. Ketamine hepato-toxicity in chronic pain management: another example of unexpected toxicity or a predicted result from previous clinical and pre-clinical data?
    Sear JW
    Pain; 2011 Sep; 152(9):1946-1947. PubMed ID: 21555186
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Noppers et al., Drug-induced liver injury following a reported course of ketamine treatment for chronic pain in CRPS type I patients. A report on 3 cases. Pain 2011;152:2173-8.
    Westerling D; Lindblom P
    Pain; 2012 Feb; 153(2):502. PubMed ID: 22154331
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug-induced liver injury following a repeated course of ketamine treatment for chronic pain in CRPS type 1 patients: a report of 3 cases.
    Noppers IM; Niesters M; Aarts LPHJ; Bauer MCR; Drewes AM; Dahan A; Sarton EY
    Pain; 2011 Sep; 152(9):2173-2178. PubMed ID: 21546160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of prolonged mania during ketamine therapy for reflex sympathetic dystrophy.
    Ricke AK; Snook RJ; Anand A
    Biol Psychiatry; 2011 Aug; 70(4):e13-4. PubMed ID: 21529780
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of sub-anesthetic intravenous ketamine and adjuvant dexmedetomidine when treating acute pain from CRPS.
    Nama S; Meenan DR; Fritz WT
    Pain Physician; 2010; 13(4):365-8. PubMed ID: 20648205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous ketamine infusions for chronic algodystrophy: a review.
    Żyluk A; Pastuszka J
    Pol Orthop Traumatol; 2014 Apr; 79():37-40. PubMed ID: 24710331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substantial Elevation of Liver Enzymes During Ketamine Infusion: A Case Report.
    Zhu X; Kohan LR; Goldstein RB
    A A Pract; 2020 Jun; 14(8):e01239. PubMed ID: 32643900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reply to: Subanesthetic dose ketamine does not induce an affective switch in three independent samples of treatment-resistant major depression.
    Altinay M; Anand A
    Biol Psychiatry; 2013 Nov; 74(10):e25. PubMed ID: 23726510
    [No Abstract]   [Full Text] [Related]  

  • 9. Subanesthetic dose ketamine does not induce an affective switch in three independent samples of treatment-resistant major depression.
    Niciu MJ; Luckenbaugh DA; Ionescu DF; Mathews DC; Richards EM; Zarate CA
    Biol Psychiatry; 2013 Nov; 74(10):e23-4. PubMed ID: 23726512
    [No Abstract]   [Full Text] [Related]  

  • 10. Ketamine for chronic noncancer pain: concerns regarding toxicity.
    Bell RF
    Curr Opin Support Palliat Care; 2012 Jun; 6(2):183-7. PubMed ID: 22436323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An observational study on the effect of S+-ketamine on chronic pain versus experimental acute pain in Complex Regional Pain Syndrome type 1 patients.
    Sigtermans M; Noppers I; Sarton E; Bauer M; Mooren R; Olofsen E; Dahan A
    Eur J Pain; 2010 Mar; 14(3):302-7. PubMed ID: 19540140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Compound Analgesic Cream (Ketamine, Pentoxifylline, Clonidine, DMSO) for Complex Regional Pain Syndrome Patients.
    Russo MA; Santarelli DM
    Pain Pract; 2016 Jan; 16(1):E14-20. PubMed ID: 26547813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetic-pharmacodynamic modeling of ketamine-induced pain relief of chronic pain.
    Dahan A; Olofsen E; Sigtermans M; Noppers I; Niesters M; Aarts L; Bauer M; Sarton E
    Eur J Pain; 2011 Mar; 15(3):258-67. PubMed ID: 20638877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A unique presentation of complex regional pain syndrome type I treated with a continuous sciatic peripheral nerve block and parenteral ketamine infusion: a case report.
    Everett A; Mclean B; Plunkett A; Buckenmaier C
    Pain Med; 2009 Sep; 10(6):1136-9. PubMed ID: 19744217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term epidural ketamine, morphine and bupivacaine attenuate reflex sympathetic dystrophy neuralgia.
    Lin TC; Wong CS; Chen FC; Lin SY; Ho ST
    Can J Anaesth; 1998 Feb; 45(2):175-7. PubMed ID: 9512855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Complex regional pain syndrome--pathophysiology, clinical presentation and treatment].
    Perić P
    Reumatizam; 2013; 60(2):67-80. PubMed ID: 24980000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analgesic effects of ketamine ointment in patients with complex regional pain syndrome type 1.
    Ushida T; Tani T; Kanbara T; Zinchuk VS; Kawasaki M; Yamamoto H
    Reg Anesth Pain Med; 2002; 27(5):524-8. PubMed ID: 12373705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic effects of ketamine administration for 2 weeks in rats.
    Kalkan Y; Tomak Y; Altuner D; Tumkaya L; Bostan H; Yilmaz A; Unal D; Kara A; Turan A
    Hum Exp Toxicol; 2014 Jan; 33(1):32-40. PubMed ID: 23386779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketamine treatment for intractable pain in a patient with severe refractory complex regional pain syndrome: a case report.
    Shirani P; Salamone AR; Schulz PE; Edmondson EA
    Pain Physician; 2008; 11(3):339-42. PubMed ID: 18523505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current management of reflex sympathetic dystrophy syndrome (complex regional pain syndrome type I).
    Berthelot JM
    Joint Bone Spine; 2006 Oct; 73(5):495-9. PubMed ID: 16837228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.